IBDEI1QE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30628,2)
 ;;=^5002040
 ;;^UTILITY(U,$J,358.3,30629,0)
 ;;=D25.9^^178^1924^64
 ;;^UTILITY(U,$J,358.3,30629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30629,1,3,0)
 ;;=3^Leiomyoma of uterus, unspecified
 ;;^UTILITY(U,$J,358.3,30629,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,30629,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,30630,0)
 ;;=D28.0^^178^1924^21
 ;;^UTILITY(U,$J,358.3,30630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30630,1,3,0)
 ;;=3^Benign neoplasm of vulva
 ;;^UTILITY(U,$J,358.3,30630,1,4,0)
 ;;=4^D28.0
 ;;^UTILITY(U,$J,358.3,30630,2)
 ;;=^267650
 ;;^UTILITY(U,$J,358.3,30631,0)
 ;;=D06.9^^178^1924^23
 ;;^UTILITY(U,$J,358.3,30631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30631,1,3,0)
 ;;=3^Carcinoma in situ of cervix, unspecified
 ;;^UTILITY(U,$J,358.3,30631,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,30631,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,30632,0)
 ;;=D06.0^^178^1924^24
 ;;^UTILITY(U,$J,358.3,30632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30632,1,3,0)
 ;;=3^Carcinoma in situ of endocervix
 ;;^UTILITY(U,$J,358.3,30632,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,30632,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,30633,0)
 ;;=D06.1^^178^1924^25
 ;;^UTILITY(U,$J,358.3,30633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30633,1,3,0)
 ;;=3^Carcinoma in situ of exocervix
 ;;^UTILITY(U,$J,358.3,30633,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,30633,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,30634,0)
 ;;=D06.7^^178^1924^26
 ;;^UTILITY(U,$J,358.3,30634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30634,1,3,0)
 ;;=3^Carcinoma in situ of other parts of cervix
 ;;^UTILITY(U,$J,358.3,30634,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,30634,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,30635,0)
 ;;=E28.2^^178^1924^79
 ;;^UTILITY(U,$J,358.3,30635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30635,1,3,0)
 ;;=3^Polycystic ovarian syndrome
 ;;^UTILITY(U,$J,358.3,30635,1,4,0)
 ;;=4^E28.2
 ;;^UTILITY(U,$J,358.3,30635,2)
 ;;=^5002749
 ;;^UTILITY(U,$J,358.3,30636,0)
 ;;=N60.11^^178^1924^38
 ;;^UTILITY(U,$J,358.3,30636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30636,1,3,0)
 ;;=3^Diffuse cystic mastopathy of right breast
 ;;^UTILITY(U,$J,358.3,30636,1,4,0)
 ;;=4^N60.11
 ;;^UTILITY(U,$J,358.3,30636,2)
 ;;=^5015773
 ;;^UTILITY(U,$J,358.3,30637,0)
 ;;=N60.12^^178^1924^37
 ;;^UTILITY(U,$J,358.3,30637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30637,1,3,0)
 ;;=3^Diffuse cystic mastopathy of left breast
 ;;^UTILITY(U,$J,358.3,30637,1,4,0)
 ;;=4^N60.12
 ;;^UTILITY(U,$J,358.3,30637,2)
 ;;=^5015774
 ;;^UTILITY(U,$J,358.3,30638,0)
 ;;=N64.4^^178^1924^70
 ;;^UTILITY(U,$J,358.3,30638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30638,1,3,0)
 ;;=3^Mastodynia
 ;;^UTILITY(U,$J,358.3,30638,1,4,0)
 ;;=4^N64.4
 ;;^UTILITY(U,$J,358.3,30638,2)
 ;;=^5015794
 ;;^UTILITY(U,$J,358.3,30639,0)
 ;;=N63.^^178^1924^66
 ;;^UTILITY(U,$J,358.3,30639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30639,1,3,0)
 ;;=3^Lump in Breast,Unspec
 ;;^UTILITY(U,$J,358.3,30639,1,4,0)
 ;;=4^N63.
 ;;^UTILITY(U,$J,358.3,30639,2)
 ;;=^5015791
 ;;^UTILITY(U,$J,358.3,30640,0)
 ;;=N70.01^^178^1924^12
 ;;^UTILITY(U,$J,358.3,30640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30640,1,3,0)
 ;;=3^Acute salpingitis
 ;;^UTILITY(U,$J,358.3,30640,1,4,0)
 ;;=4^N70.01
 ;;^UTILITY(U,$J,358.3,30640,2)
 ;;=^5015802
 ;;^UTILITY(U,$J,358.3,30641,0)
 ;;=N70.02^^178^1924^11
 ;;^UTILITY(U,$J,358.3,30641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30641,1,3,0)
 ;;=3^Acute oophoritis
 ;;^UTILITY(U,$J,358.3,30641,1,4,0)
 ;;=4^N70.02
 ;;^UTILITY(U,$J,358.3,30641,2)
 ;;=^5015803
 ;;
 ;;$END ROU IBDEI1QE
